Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors (2017)
- Authors:
- USP affiliated authors: BARBUTO, JOSÉ ALEXANDRE MARZAGÃO - ICB ; BOSCARDIN, SILVIA BEATRIZ - ICB ; FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- DOI: 10.1158/1535-7163.MCT-17-0071
- Subjects: IMUNOLOGIA; MICROBIOLOGIA; PARASITOLOGIA; HERPES SIMPLES; PAPILLOMAVIRUS; VACINAS VIRAIS; NEOPLASIAS DO COLO UTERINO
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2017
- Source:
- Título: Molecular Cancer Therapeutics
- ISSN: 1538-8514
- Volume/Número/Paginação/Ano: v. 16, n. 9, p. 1922-1933, 2017
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
RIBEIRO, Bruna Felício Milazzotto Maldonado Porchia et al. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors. Molecular Cancer Therapeutics, v. 16, n. 9, p. 1922-1933, 2017Tradução . . Disponível em: https://doi.org/10.1158/1535-7163.MCT-17-0071. Acesso em: 31 mar. 2026. -
APA
Ribeiro, B. F. M. M. P., Moreno, A. C. R., Ramos, R. N., Diniz, M. de O. L., Andrade, L. H. T. M. de, Rosa, D. S., et al. (2017). Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors. Molecular Cancer Therapeutics, 16( 9), 1922-1933. doi:10.1158/1535-7163.MCT-17-0071 -
NLM
Ribeiro BFMMP, Moreno ACR, Ramos RN, Diniz M de OL, Andrade LHTM de, Rosa DS, Barbuto JAM, Boscardin SB, Ferreira LC de S. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors [Internet]. Molecular Cancer Therapeutics. 2017 ; 16( 9): 1922-1933.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1158/1535-7163.MCT-17-0071 -
Vancouver
Ribeiro BFMMP, Moreno ACR, Ramos RN, Diniz M de OL, Andrade LHTM de, Rosa DS, Barbuto JAM, Boscardin SB, Ferreira LC de S. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors [Internet]. Molecular Cancer Therapeutics. 2017 ; 16( 9): 1922-1933.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1158/1535-7163.MCT-17-0071 - CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein
- The dengue virus non-structural 1 protein: risks and benefits
- Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein
- Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
- A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses
- Parenteral adjuvant effects of an enterotoxigenic Escherichia coli natural heat-labile toxin variant
- Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses
- Dendritic cells in tolerance and immunity against pathogens
- Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii
- Adjuvants: classification, Modus Operandi, and licensing.
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
